The Biodue and HairDX introduce the Hair Loss Test, pioneers genetic test for predicting the risk of male and female hair loss. Today, announced an exclusive agreement with Biodue Srl, Florence, Italy. Pharmacogenomics research and development innovator PharmaGenoma, Inc and its subsidiary HairDX.

The agreement makes Biodue the sole distributor of revolutionary genetic tests in Italy, and expands the company’s leadership in the hair dermatology.

Andy Goren, President and CEO of PharmaGenoma, Inc. said “PharmaGenoma is a leader in molecular dermatology and is excited to bring the latest in genetic science to Italy. The partnership with Biodue will benefit Italian men and women concerned about hair loss.”

Ruffo Benedetti, General Manager of Biodue said “We are very excited to introduce the HairDX’s genetic test in Italy as the European launch customer. We believe this test will be of great help to Italian Dermatologists while treating and diagnosing hair loss”

HairDX, easy to use genetic test, to get an accurate and understandable genetic analysis of a man’s or woman’s likelihood of developing Androgenetic Alopecia, the most common type of hair loss.